Related Experiment Videos
Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype
K C Hoffbuhr1, L M Moses, M A Jerdonek
1Research Center for Genetic Medicine, Children's National Medical Center, Washington D.C 20010, USA.
Summary
Mutations in the methyl CpG binding protein 2 (MeCP2) gene cause Rett syndrome, a neurodevelopmental disorder affecting girls. Clinical presentation varies due to complex interactions between MeCP2 mutations and X-inactivation patterns.
Area of Science:
- Neuroscience
- Genetics
- Developmental Biology
Background:
- Rett syndrome is a severe neurodevelopmental disorder impacting early brain growth in girls.
- Characterized by developmental regression, loss of skills, head growth deceleration, and hand stereotypies.
- Most cases are linked to mutations in the methyl CpG binding protein 2 (MeCP2) gene.
Purpose of the Study:
- To explore the genetic basis of Rett syndrome.
- To understand the role of MeCP2 gene mutations and X-inactivation in disease presentation.
- To investigate the wide spectrum of clinical phenotypes associated with MeCP2 mutations.
Main Methods:
- Analysis of MeCP2 gene mutations in patients with Rett syndrome.
- Examination of X-inactivation patterns in affected females.
- Correlation of genotype and X-inactivation status with clinical phenotypes.
Main Results:
- Mutations in the MeCP2 gene are the primary cause of typical Rett syndrome.
- Mosaic expression of MeCP2 defects and varying X-inactivation patterns influence disease severity.
- A broad spectrum of clinical phenotypes, including variants and related disorders, arise from MeCP2 mutations.
Conclusions:
- The MeCP2 gene is crucial for normal neurodevelopment.
- X-inactivation patterns significantly modulate the clinical expression of Rett syndrome.
- Understanding the genotype-phenotype relationship, including modifiers, is key to comprehending Rett syndrome's variability.